Lyell Immunopharma Inc
NASDAQ:LYEL

Watchlist Manager
Lyell Immunopharma Inc Logo
Lyell Immunopharma Inc
NASDAQ:LYEL
Watchlist
Price: 31.59 USD -12.37% Market Closed
Market Cap: 670.3m USD

Intrinsic Value

The intrinsic value of one LYEL stock under the Base Case scenario is hidden USD. Compared to the current market price of 31.59 USD, Lyell Immunopharma Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

LYEL Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Lyell Immunopharma Inc

Intrinsic Value History
Dive into the past to invest in the future

LYEL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LYEL usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about LYEL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LYEL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lyell Immunopharma Inc.

Explain Valuation
Compare LYEL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LYEL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lyell Immunopharma Inc

Current Assets 328m
Cash & Short-Term Investments 319.6m
Other Current Assets 8.4m
Non-Current Assets 80m
Long-Term Investments 19m
PP&E 57m
Other Non-Current Assets 4m
Current Liabilities 32m
Accounts Payable 2.6m
Accrued Liabilities 29m
Other Current Liabilities 430k
Non-Current Liabilities 47m
Other Non-Current Liabilities 47m
Efficiency

Free Cash Flow Analysis
Lyell Immunopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lyell Immunopharma Inc

Revenue
41k USD
Operating Expenses
-201.6m USD
Operating Income
-201.6m USD
Other Expenses
-124.4m USD
Net Income
-326m USD
Fundamental Scores

LYEL Profitability Score
Profitability Due Diligence

Lyell Immunopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Lyell Immunopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

LYEL Solvency Score
Solvency Due Diligence

Lyell Immunopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Lyell Immunopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LYEL Price Targets Summary
Lyell Immunopharma Inc

Wall Street analysts forecast LYEL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LYEL is 30.26 USD with a low forecast of 12.12 USD and a high forecast of 47.25 USD.

Lowest
Price Target
12.12 USD
62% Downside
Average
Price Target
30.26 USD
4% Downside
Highest
Price Target
47.25 USD
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lyell Immunopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LYEL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LYEL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LYEL stock?

The intrinsic value of one LYEL stock under the Base Case scenario is hidden USD.

Is LYEL stock undervalued or overvalued?

Compared to the current market price of 31.59 USD, Lyell Immunopharma Inc is hidden .

Back to Top